title: Complementary and alternative medical treatment of breast cancer: a survey of licensed North American naturopathic physicians.
abstract: BACKGROUND
  Complementary and alternative medicine (CAM) use is on the rise in the United States, especially for breast cancer patients. Many CAM therapies are delivered by licensed naturopathic physicians using individualized treatment plans.
  
  
  OBJECTIVE
  To describe naturopathic treatment for women with breast cancer.
  
  
  METHODS
  Cross-sectional mail survey in 2 parts: screening form and 13-page survey.
  
  
  METHODS
  Bastyr University Cancer Research Center, Kenmore, Wash.
  
  
  METHODS
  All licensed naturopathic physicians in the United States and Canada (N=1,356) received screening forms; 642 (47%) completed the form. Of the respondents, 333 (52%) were eligible, and 161 completed the survey (48%).
  
  
  METHODS
  Demographics of naturopathic physicians, development of treatment plans, CAM therapies used, perceived efficacy of therapeutic interventions.
  
  
  RESULTS
  Of those respondents screened, 497 (77%) had provided naturopathic care to women with breast cancer, and 402 (63%) had treated women with breast cancer in the previous 12 months. Naturopaths who were women were more likely than men to treat breast cancer (P < or = .004). Of the survey respondents, 104 (65%) practiced in the United States, and 57 (35%) practiced in Canada; 107 (66.5%) were women, and 54 (33.5%) were men. To develop naturopathic treatment plans, naturopathic physicians most often considered the stage of cancer, the patient's emotional constitution, and the conventional therapies used. To monitor patients clinically, 64% of the naturopathic physicians used diagnostic imaging, 57% considered the patient's quality of life, and 51% used physical examinations. The most common general CAM therapies used were dietary counseling (94%), botanical medicines (88%), antioxidants (84%), and supplemental nutrition (84%). The most common specific treatments were vitamin C (39%), coenzyme Q-10 (34%), and Hoxsey formula (29%).
authors.affiliation: University Research Institute, Kenmore, Wash, USA.
authors.forename: Leanna J
authors.initials: LJ
authors.lastname: Standish
authors.forename: Käri
authors.initials: K
authors.lastname: Greene
authors.forename: Heather
authors.initials: H
authors.lastname: Greenlee
authors.forename: Jung G
authors.initials: JG
authors.lastname: Kim
authors.forename: Cheryl
authors.initials: C
authors.lastname: Grosshans
mesh_terms: D000328:Adult; D001291:Attitude of Health Personnel; D001943:Breast Neoplasms / Q000628:therapy*; D002170:Canada; D000529:Complementary Therapies / Q000592:standards*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009324:Naturopathy / Q000592:standards; D010817:Physician-Patient Relations; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011788:Quality of Life; D011795:Surveys and Questionnaires; D014481:United States; D016387:Women's Health